Anupam Rasayan India Ltd

• Anupam Rasayan India Share Price Analysis After 5.55% Fall
  Univest · 08 Oct 2026
• Anupam Rasayan deepens pharma push with Bliss GVS buy, eyes ₹4,000 crore platform
  Indiatimes · 01 Oct 2026
• Anupam Rasayan takes control of Bliss GVS in ₹1,750 crore bet on pharma scale-up
  Indiatimes · 30 Sep 2026
• How Anupam Rasayan plans to double Bliss GVS Pharma's rev in three years
  CNBC TV18 · 30 Sep 2026
• Anupam Rasayan promoter Mona Desai pledges 14.6 lakh shares
  scanx.trade · 30 Sep 2026
• Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
  BusinessLine · 29 Sep 2026
• Anupam Rasayan Acquires Bliss GVS Pharma for Rs 1,750 Cr
  Rediff MoneyWiz · 29 Sep 2026
• Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platform
  The Economic Times · 29 Sep 2026
• Anupam Rasayan completes Rs. 1,750 crore acquisition of Bliss GVS Pharma to build global platform
  Indian Pharma Post · 29 Sep 2026
• Anupam Rasayan India Limited (ANURAS.NS) Slips Marginally, Holds Above ₹1,100 Support Zone - Bollinger Expansion
  https://www.siam.in/ · 29 Sep 2026
• Anupam Rasayan Completes Acquisition of Bliss GVS Pharma
  Chemical Industry Digest · 29 Sep 2026
• Anupam Rasayan India (NSEI:ANURAS) Stock Forecast & Analyst Predictions
  Simply Wall Street · 25 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →